Help
RSS
API
Feed
Maltego
Contact
Domain > press.swedenbio.se
×
Welcome!
Right click nodes and scroll the mouse to navigate the graph.
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-10-25
20.223.51.7
(
ClassC
)
Port 443
HTTP/1.1 200 OKContent-Type: text/html; charsetutf-8Date: Fri, 25 Oct 2024 10:20:47 GMTEtag: W/10960-5AboZubNEtiFhZ6+Ac+iS/FSDYQStrict-Transport-Security: max-age31536000Vary: Accept-EncodingX-Content-Type-Options: nosniffX-Frame-Options: ALLOW-FROM https://amplify.notified.comX-Powered-By: ExpressTransfer-Encoding: chunked !DOCTYPE html>html langen>head> link relcanonical hrefhttps://press.swedenbio.se/> title>SwedenBIO/title> base href/> link relicon idappFavicon hrefhttps://cdn.filestackcontent.com/YWpsS0C7Sl62uteK49TA> meta charsetutf-8> meta nameviewport contentwidthdevice-width, initial-scale1>link relstylesheet hrefstyles.59cea37f4d550494.css>link hrefhttps://use.typekit.net/ttf3esh.css typetext/css relstylesheet mediascreen,print idtypekit-font>meta propertyog:url contentpress.swedenbio.se>meta propertyog:title contentSwedenBIO>meta propertyog:type contentwebsite>meta propertyog:image contenthttps://cdn.filestackcontent.com/ADl2KZuKDRbS7BbbwOreQz/auto_image/resizewidth:1200,height:627,fit:clip,align:top/yPiTBxBMRcGyyMzTJiRR>meta propertyog:image:width content1200>meta propertyog:image:height content627>meta propertyog:description contentBranschorganisationen SwedenBIO arbetar för en konkurrenskraftig life science-sektor i Sverige. Vi gör det genom att skapa effektiva kontaktytor mellan sektorns olika aktörer, genom att bygga kunskap och genom att ge branschen en stark röst i samhällsdebatten. Våra mer än 330 medlemsföretag bedriver verksamhet inom läkemedelsutveckling, bioteknik, medicinteknik och diagnostik eller är experter inom bland annat affärsutveckling, finansiering, immaterialrätt och juridik.>meta namedescription contentBranschorganisationen SwedenBIO arbetar för en konkurrenskraftig life science-sektor i Sverige. Vi gör det genom att skapa effektiva kontaktytor mellan sektorns olika aktörer, genom att bygga kunskap och genom att ge branschen en stark röst i samhällsdebatten. Våra mer än 330 medlemsföretag bedriver verksamhet inom läkemedelsutveckling, bioteknik, medicinteknik och diagnostik eller är experter inom bland annat affärsutveckling, finansiering, immaterialrätt och juridik.>meta nametwitter:card contentsummary_large_image>meta namegoogle-site-verification contentLfCGLWgg7MsVeCRCheVB-plUCInXLCte2P1K0kxlTLE>meta namerobots contentindex, follow>style ng-transitionnotified-newsroom>.article-slide-item_ngcontent-sc28{height:250px;width:100%;background-color:#fff;box-shadow:0 2px 4px #0000001a;position:relative;border:1px solid rgb(237,237,237);overflow:hidden}.article-slide-item.no-image_ngcontent-sc28 .content-wrapper_ngcontent-sc28{opacity:1;transform:translateZ(0)}.article-slide-item.no-image_ngcontent-sc28 .image_ngcontent-sc28{display:none}.article-slide-item_ngcontent-sc28:hover .image_ngcontent-sc28{opacity:0;transform:translate3d(0,-250px,0)}.article-slide-item_ngcontent-sc28:hover .content-wrapper_ngcontent-sc28{opacity:1;transform:translateZ(0)}.article-slide-item_ngcontent-sc28 .image_ngcontent-sc28{position:absolute;inset:0;width:100%;height:100%;background-size:cover;background-position:center center;backface-visibility:hidden;transition:all .35s;opacity:1}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28{opacity:0;transition:opacity .35s,transform .35s;transform:translate3d(0,200px,0);position:absolute;inset:0}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28{padding:25px;position:absolute;left:0;right:0;color:#fff;top:50%;transform:translateY(-50%);opacity:1}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28 .published_ngcontent-sc28{font-size:.7rem}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28 .source_ngcontent-sc28{font-size:1rem;font-weight:600}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28 .text-wrapper_ngcontent-sc28{margin-top:7px}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28 .text-wrapper_ngcontent-sc28 .text_ngcontent-sc28{font-size:.9rem;position:relative;top:-5px}.article-slide-item_ngcontent-sc28 .content-wrapper_ngcontent-sc28 .content_ngcontent-sc28 .text-wrapper_ngcontent-sc28 .title_ngcontent-sc28{font-size:1rem;font-weight:700;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;max-width:100%;display:inline-block}.box-layout_ngcontent-sc28{list-style:none;margin:-10px;padding:0}.box-layout_ngcontent-sc28 li_ngcontent-sc28{width:calc(25% - 20px);display:inline-block;margin:10px}@media (max-width: 37.5em){.box-layout_ngcontent-sc28 li_ngcontent-sc28{width:100%;margin:0}}@media (max-width: 50em) and (min-width: 37.5em){.box-layout_ngcontent-sc28 li_ngcontent-sc28{width:calc(33.33% - 20px)}}@media (max-width: 37.5em){.box-layout_ngcontent-sc28{margin:0}}.list-layout_ngcontent-sc28{list-style:none;padding:0}.list-layout_ngcontent-sc28 li_ngcontent-sc28{width:100%;display:block;margin-bottom:25px;overflow:hidden;padding-bottom:25px;border-bottom:1px solid rgba(0,0,0,.1)}.list-layout_ngcontent-sc28 li_ngcontent-sc28:last-child{margin-bottom:0}.list-layout_ngcontent-sc28 li_ngcontent-sc28 a_ngcontent-sc28{color:#666;text-decoration:none}.list-layout_ngcontent-sc28 li_ngcontent-sc28 a_ngcontent-sc28:hover{text-decoration:none}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 img_ngcontent-sc28{float:left;max-width:150px;height:auto}@media (max-width: 37.5em){.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 img_ngcontent-sc28{float:none;width:100%;height:auto;margin-bottom:10px;max-width:100%}}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28{margin-left:170px}@media (max-width: 37.5em){.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28{margin-left:0}}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28 .title_ngcontent-sc28{font-weight:800;color:#333;font-size:18px;margin-bottom:0}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28 .text_ngcontent-sc28{font-style:italic;font-size:17px;color:#333;font-weight:300}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28 .source_ngcontent-sc28{font-weight:600;text-transform:uppercase;color:#666;font-size:13px}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item_ngcontent-sc28 .content_ngcontent-sc28 .published_ngcontent-sc28{margin-right:3px;font-weight:600;color:#666;font-size:13px;text-transform:uppercase}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item.no-image_ngcontent-sc28 img_ngcontent-sc28{display:none}.list-layout_ngcontent-sc28 li_ngcontent-sc28 .article-list-item.no-image_ngcontent-sc28 .content_ngcontent-sc28{margin-left:0}/style>/head>body> style idnewsroom_styles>@font-face {font-family: Inter; src: url(https://cdn.filestackcontent.com/Vvkc97QSLC9JF4JP6vWg) format(truetype);} body{ font-family: proxima-nova-1}.btn{ font-family: proxima-nova-1}h1,h2,h3,h4,h5,h6{ font-family: abril-text-1}a{ color: #c51162}a:hover{ color: #c51162; opacity: 0.8;}.lSSlideOuter .lSPager.lSpg > li:hover a, .lSSlideOuter .lSPager.lSpg > li.active a { background-color: #c51162 ;}.content-container h1 .seperator { background-color: #c51162 ;}.navbar .nav-item .nav-link.active { border-color: #c51162;}.view-more-button-container .btn { background: #c51162;}.color-newsroom-accent-color{ color: #c51162;}.bg-color-newsroom-accent-color{ background: #c51162;}.item-list-boxed ul li .box .read-more-container{ background-color: #c51162;}.item-list-boxed ul li .box .social-icons{ color: #c51162;}.btn.btn-default { background-color: #c51162; border-color: #c51162; color: #fff; border-radius:2px;}.btn.btn-default:hover { background-color: #c51162; border-color: #c51162; color: #fff; opacity:0.5;}.newsroom-section-loader .circular, .newsroom-loader .circular{ stroke: #c51162;}.item-list .list-no-items { background-color: #c51162;}.modal .modal-dialog .modal-content { border-color: #c51162;}.control-checkbox:hover input:not(disabled):checked ~ .indicator, .control-checkbox .control input:checked:focus ~ .indicator { background: #c51162;}.control-checkbox input:checked:not(disabled) ~ .indicator { background: #c51162;}.btn.btn-sm { padding: .25rem .5rem; font-size: .875rem; line-height: 1.5; border-radius: .2rem;}.btn{ font-size: 1rem; padding: .375rem .75rem;}.dropdown .dropdown-menu .dropdown-item.active,.dropup .dropdown-menu .dropdown-item.active { color: #c51162}.cookie-consent-container{ background: #c51162;}ngb-pagination .page-item.active .page-link { color: #fff; background-color: #c51162; border-color: #c51162; }ngb-pagination .page-link:hover { color: #c51162;}.press-kit-card .media-list .dataobject-item .info-container { background-color: #c51162;}/style> style idcustom_styles>h1,h2,h3,h4,h5,h6{ font-family: Inter}body{ font-family: Inter}.btn{ font-family: Inter}.powered-by-footer { background-color: rgb(252,252,253); color: rgb(179,179,179);}.powered-by-footer a { color:rgb(179,179,179);}.navbar .navbar-brand img { height: 57px;}.navbar .navbar-brand { top: 9px;}.navbar { background-color: rgb(252,252,253)!important; }.navbar-light .navbar-nav .nav-link { color:rgb(179,179,179); }/style> notified-newsroom _nghost-sc21 ng-version15.2.10 ng-server-contextother>router-outlet _ngcontent-sc21>/router-outlet>ng-component>!---->div classnewsroom-wrapper newsroom-frontpage>div classnewsroom-top-nav>nav idmain-navbar classnavbar navbar-expand-lg navbar-light bg-faded fixed-top>!---->a classnavbar-brand href/>img classimg-fluid srchttps://cdn.filestackcontent.com/GtKTfRGfTbivkX2soNno altSwedenBIO logo>!---->/a>!---->button typebutton data-togglecollapse data-target#navbarSupportedContent aria-controlsnavbarSupportedContent aria-expandedfalse aria-labelToggle navigation classnavbar-toggler>span classnavbar-toggler-icon>/span>/button>div classcollapse navbar-collapse>button typebutton classmobile-toggle-cancel>i classicon-cancel-1>/i>/button>ul classnavbar-nav ml-auto>li classnav-item>a routerlinkactiveactive classnav-link active href/>Hem/a>/li>!---->!---->li classnav-item>a routerlinkactiveactive classnav-link href/presskits>Pressmaterial/a>/li>!---->li classnav-item>a routerlinkactiveactive classnav-link href/contacts>Kontaktpersoner/a>/li>!---->li classnav-item>a classnav-link hrefhttps://swedenbio.se>swedenbio.se/a>/li>!---->!---->!---->!---->!---->!---->!---->!---->li idfollow-button-menu classnav-item>button typebutton classbtn btn-default pr-4 pl-4>Följ/button>/li>/ul>/div>/nav>/div>!---->!---->div classnewsroom-content>router-outlet>/router-outlet>ng-component>div idfrontpage class>section class>!---->newsroom-header>div classnewsroom-hero-container>div classcontent>h1 classtitle stylecolor:rgb(255,255,255);>Välkommen till SwedenBIOs pressrum/h1>!---->hr classtitle-seperator styleborder-color:rgb(255,255,255);>!---->!---->div idfollow-button-header classbuttons-container>button classbtn btn-round btn-white stylecolor:rgb(255,255,255);background-color:rgb(255,187,31);>Följ/button>/div>/div>!---->div classimage-overlay stylebackground-color:rgba(0,0,0,0.07);>/div>!---->div classimage-container stylebackground-image:url(https://cdn.filestackcontent.com/yPiTBxBMRcGyyMzTJiRR);filter:blur(0px);>/div>!---->/div>!---->/newsroom-header>/section>!---->!---->!---->!---->section class>!---->items-widget idwidget-26066 classwidget-container>div classcontent-container>div classcontainer>div classrow>div classcol-lg-12>h1>Pressmeddelanden span classseperator>/span>/h1>!---->div classitem-list-boxed>ul>li classwidth-50>div classbox>div classtext-content-container>a classtext-content-link href/posts/pressreleases/mycural-therapeutics-wins-nordic-star-pitch-c>div classtext-wrapper>div classpublished>2024-09-20 07:31/div>div classtype stylecolor:#c51162;>Pressmeddelande/div>h5 classtitle>MyCural Therapeutics wins Nordic Star Pitch Competition/h5>div classsummary>MyCural Therapeutics awed the audience at Nordic Life Science Days and took home the prize at the premier Nordic Life Science partnering conference. /div>/div>/a>div classsocial-icons>!---->!---->!---->!---->/div>/div>div classimage-container>a href/posts/pressreleases/mycural-therapeutics-wins-nordic-star-pitch-c>div classimage-holder stylebackground-image:url(https://cdn.filestackcontent.com/auto_image/1OgEpl9lTISQlqmUHpCs);>/div>!---->/a>/div>a classread-more-container href/posts/pressreleases/mycural-therapeutics-wins-nordic-star-pitch-c> Läs mer /a>/div>/li>li classwidth-50>div classbox>div classtext-content-container>a classtext-content-link href/posts/pressreleases/nlsdays-premier-nordic-life-science-event-att>div classtext-wrapper>div classpublished>2024-09-11 07:30/div>div classtype stylecolor:#c51162;>Pressmeddelande/div>h5 classtitle>NLSDays: Premier Nordic Life Science Event Attracts Investors to Malmö/h5>div classsummary>NLSDays, the premier Nordic life science event, is returning to Malmö, Sweden, on September 18-19. The international conference is set to draw a di.../div>/div>/a>div classsocial-icons>!---->!---->!---->!---->/div>/div>div classimage-container>a href/posts/pressreleases/nlsdays-premier-nordic-life-science-event-att>div classimage-holder stylebackground-image:url(https://cdn.filestackcontent.com/auto_image/MlaHlyKRwkWEkwKQANyA);>/div>!---->/a>/div>a classread-more-container href/posts/pressreleases/nlsdays-premier-nordic-life-science-event-att> Läs mer /a>/div>/li>li classwidth-50>div classbox>div classtext-content-container>a classtext-content-link href/posts/pressreleases/swedish-and-danish-life-science-experiencing>div classtext-wrapper>div classpublished>2024-08-20 09:44/div>div classtype stylecolor:#c51162;>Pressmeddelande/div>h5 classtitle>Swedish and Danish Life Science experiencing substantial growth /h5>div classsummary>The life science sectors in Sweden and Denmark are experiencing impressive growth, solidifying the position of the Nordic region as a key player in.../div>/div>/a>div classsocial-icons>!---->!---->!---->!---->/div>/div>div classimage-container>a href/posts/pressreleases/swedish-and-danish-life-science-experiencing>div classimage-holder stylebackground-image:url(https://cdn.filestackcontent.com/auto_image/fojLeIS8T9i5hUoaL273);>/div>!---->/a>/div>a classread-more-container href/posts/pressreleases/swedish-and-danish-life-science-experiencing> Läs mer /a>/div>/li>li classwidth-50>div classbox no-image>div classtext-content-container>a classtext-content-link href/posts/pressreleases/valkommet-regeringsbesked-om-kliniska-provnin>div classtext-wrapper>div classpublished>2024-06-28 09:39/div>div classtype stylecolor:#c51162;>Pressmeddelande/div>h5 classtitle>Välkommet regeringsbesked om kliniska prövningar /h5>div classsummary>Regeringen gav igår ett viktigt besked kring hur Sverige ska nå målet om att öka antalet kliniska prövningar. SwedenBIO välkomnar beslutet som bygg.../div>/div>/a>div classsocial-icons>!---->!---->!---->!---->/div>/div>div classimage-container>a href/posts/pressreleases/valkommet-regeringsbesked-om-kliniska-provnin>!---->/a>/div>a classread-more-container href/posts/pressreleases/valkommet-regeringsbesked-om-kliniska-provnin> Läs mer /a>/div>/li>!---->/ul>div classclearfix>/div>/div>!---->!---->!---->div classview-more-button-container>!---->a classbtn btn-read-more href/posts>Visa fler/a>!---->/div>!---->!---->!---->/div>/div>/div>/div>!---->/items-widget>/section>!---->!---->!---->!---->!---->!---->section class>!---->tag-based-items-widget _nghost-sc28 idwidget-55755 classodd widget-container>div _ngcontent-sc28 classcontent-container>div _ngcontent-sc28 classcontainer>div _ngcontent-sc28 classrow>div _ngcontent-sc28 classcol-lg-12>h1 _ngcontent-sc28>Opinion & debatt span _ngcontent-sc28 classseperator>/span>/h1>!---->!---->!---->!---->!---->div _ngcontent-sc28 classnewsroom-section-loader mb-0>svg _ngcontent-sc28 viewBox25 25 50 50 classcircular>circle _ngcontent-sc28 cx50 cy50 r20 fillnone stroke-width2 stroke-miterlimit10 classpath>/circle>/svg>/div>!---->!---->!---->/div>/div>/div>/div>!---->/tag-based-items-widget>/section>!---->!---->!---->!---->!---->!---->!---->!---->section class>!---->tag-based-items-widget _nghost-sc28 idwidget-26067 classwidget-container>div _ngcontent-sc28 classcontent-container>div _ngcontent-sc28 classcontainer>div _ngcontent-sc28 classrow>div _ngcontent-sc28 classcol-lg-12>h1 _ngcontent-sc28>Om oss i media span _ngcontent-sc28 classseperator>/span>/h1>!---->!---->ul _ngcontent-sc28 classlist-layout>!---->/ul>!---->!---->!---->!---->div _ngcontent-sc28 classnewsroom-section-loader mb-0>svg _ngcontent-sc28 viewBox25 25 50 50 classcircular>circle _ngcontent-sc28 cx50 cy50 r20 fillnone stroke-width2 stroke-miterlimit10 classpath>/circle>/svg>/div>!---->!---->!---->/div>/div>/div>/div>!---->/tag-based-items-widget>/section>!---->!---->!---->!---->!---->!---->!---->!---->section class>!---->tag-based-items-widget _nghost-sc28 idwidget-43661 classodd widget-container>div _ngcontent-sc28 classcontent-container>div _ngcontent-sc28 classcontainer>div _ngcontent-sc28 classrow>div _ngcontent-sc28 classcol-lg-12>h1 _ngcontent-sc28>Branschnyheter span _ngcontent-sc28 classseperator>/span>/h1>!---->!---->!---->!---->!---->div _ngcontent-sc28 classnewsroom-section-loader mb-0>svg _ngcontent-sc28 viewBox25 25 50 50 classcircular>circle _ngcontent-sc28 cx50 cy50 r20 fillnone stroke-width2 stroke-miterlimit10 classpath>/circle>/svg>/div>!---->!---->!---->/div>/div>/div>/div>!---->/tag-based-items-widget>/section>!---->!---->!---->!---->!---->!---->!---->!---->!---->section class>!---->html-widget idwidget-26069 classwidget-container>div classcontent-container>div classcontainer>div classrow>div classcol-lg-12>h1>Om SwedenBIO span classseperator>/span>/h1>!---->div classcompany-info-about pre-wrap>p>Branschorganisationen SwedenBIO arbetar för en konkurrenskraftig life science-sektor i Sverige. Vi gör det genom att skapa effektiva kontaktytor mellan sektorns olika aktörer, genom att bygga kunskap och genom att ge branschen en stark röst i samhällsdebatten./p>p>Våra a hrefhttps://shared.outlook.inky.com/link?domainswedenbio.se&teyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxlkNFrwjAQxv-XPGutXfuwgqA4HI41ItR1LYJcmhtpTVKXxLp17H9f-ja2t7v7-N19330Rh6AaTlLSaGeAd2QyVmg0SJK-gbQ4Iehl3dSdxECAHjq9tDfkqFnTBRY9MfJ_RlfjeSKcu6TH2XH2Wz3OejAwVcglKgXmf-_53YGk-irlhDhhENxJYo9-Zej9jeegSMJabc7s8_6dRUIwlYhndZFMU8maeVu-PtmqSFY8ehn4OmlZFPZVsY-rfBvRgZ-ztg5ptP_I1D6mD3VStdu7sshC-rgR5XDus_yQ7PJyvssPN7qOY7paLMZYFs0JFTTyBJwbtNZ7aTv_Fg1Bi9qintZgJOrlDa0L6k6R7x_YAHpR.MEQCIDp8co2SyuJQvXUv-cwts0BDdB6OFWCzYUokISyCrOVQAiB7WW4Wp_JnXuW9W-EKjapnkQrdjEl2FfKNsdAxa8-lBA target_blank relnoopener noreferrer data-authNotApplicable>mer än 300 medlemsföretag/a> har totalt 20 000 anställda och bedriver verksamhet inom läkemedelsutveckling, bioteknik, medicinteknik och diagnostik eller är experter inom bland annat affärsutveckling, finansiering, immaterialrätt och juridik./p>/div>/div>/div>/div>/div>!---->/html-widget>/section>!---->!---->!---->!---->!---->!---->section class>!---->contact-widget idwidget-26070 classodd widget-container>div classcontent-container>div classcontainer>div classrow>div classcol-lg-12>h1>Kontaktpersoner span classseperator>/span>/h1>!---->div classcontacts-big-list>div classcontacts-list row>div classcol-lg-6 col-sm-12 col-xs-12 contact-col>div classcontact-item contact-col>img classcontact-image srchttps://cdn.filestackcontent.com/auto_image/YKJvWojiSRCVT7SSDE1p altJessica Martinsson>!---->div classcontact-info>div classtitle stylecolor:#c51162;>CEO & Director General/div>!---->h5 classcontact-name> Jessica Martinsson /h5>!---->!---->ul>li>i classicon-mail-1>/i>a classpointer hrefmailto:jessica.martinsson@swedenbio.se>jessica.martinsson@swedenbio.se/a>/li>!---->!---->!---->!---->!---->!---->/ul>/div>/div>/div>div classcol-lg-6 col-sm-12 col-xs-12 contact-col>div classcontact-item contact-col>img classcontact-image srchttps://cdn.filestackcontent.com/auto_image/iaWDsiQkmuCYjVlwCjFw altAfram Yakoub>!---->div classcontact-info>div classtitle stylecolor:#c51162;>Communications Manager/div>!---->h5 classcontact-name> Afram Yakoub /h5>!---->!---->ul>li>i classicon-mail-1>/i>a classpointer hrefmailto:afram.yakoub@swedenbio.se>afram.yakoub@swedenbio.se/a>/li>!---->li>i classicon-phone>/i> +46 (0) 73 141 17 89 /li>!---->!---->!---->!---->!---->/ul>/div>/div>/div>!---->/div>/div>/div>/div>/div>/div>!---->/contact-widget>/section>!---->!---->!---->!---->!---->!---->!---->!---->!---->!---->/div>/ng-component>!---->/div>div classpowered-by-footer>div classcontainer>div classrow justify-content-center>div classsubscribe-rss col-lg-6>div classicon-rss-1>Follow us/div>ul classrss-feed-list>li>a relnofollow target_blank classml-1 hrefhttps://api.client.notified.com/api/rss/publish/view/20701?typenews>Nyheter (RSS)/a>/li>li>a relnofollow target_blank classml-1 hrefhttps://api.client.notified.com/api/rss/publish/view/20701?typepress>Pressmeddelanden (RSS)/a>/li>li>a relnofollow target_blank classml-1 hrefhttps://api.client.notified.com/api/rss/publish/view/20701?typeblog>Nyhetsbrev (RSS)/a>/li>/ul>/div>div classcol-lg-6>a hrefhttps://notified.com relnofollow target_blank>img src../../content/imgs/logos/logo_square.svg altNotified logo>Powered by Notified/a>/div>/div>/div>/div>/div>loader-container>!---->/loader-container>/ng-component>!---->/notified-newsroom> script srchttps://cdnjs.cloudflare.com/ajax/libs/limonte-sweetalert2/6.9.1/sweetalert2.min.js>/script> script srchttps://cdnjs.cloudflare.com/ajax/libs/jquery/3.5.0/jquery.min.js>/script> script srccontent/js/lightslider.min.js>/script> script srccontent/js/webfont.js>/script>script srcruntime.d8d7b20a66dbf5e1.js typemodule>/script>script srcpolyfills.21a690296e1f4fb9.js typemodule>/script>script srcmain.8079d9c3301456b5.js typemodule>/script>script idnotified-newsroom-state typeapplication/json>{&q;viewModelKey&q;:{&q;name&q;:&q;SwedenBIO&q;,&q;sluggedName&q;:&q;swedenbio-1&q;,&q;roomId&q;:20701,&q;isPublic&q;:true,&q;cameViaCustomDomain&q;:true,&q;googleAnalyticsTrackingId&q;:null,&q;googleAnalytics4TrackingId&q;:null,&q;googleAnalyticsDisabled&q;:false,&q;cookieConsentEnabled&q;:true,&q;googleSiteVerificationToken&q;:&q;LfCGLWgg7MsVeCRCheVB-plUCInXLCte2P1K0kxlTLE&q;,&q;companyInfo&q;:{&q;publishRoomId&q;:20701,&q;about&q;:&q;Branschorganisationen SwedenBIO arbetar för en konkurrenskraftig life science-sektor i Sverige. Vi gör det genom att skapa effektiva kontaktytor mellan sektorns olika aktörer, genom att bygga kunskap och genom att ge branschen en stark röst i samhällsdebatten. \n\n Våra mer än 330 medlemsföretag bedriver verksamhet inom läkemedelsutveckling, bioteknik, medicinteknik och diagnostik eller är experter inom bland annat affärsutveckling, finansiering, immaterialrätt och juridik.&q;,&q;name&q;:&q;SwedenBIO&q;,&q;hostedNewsroomDomain&q;:&q;press.swedenbio.se&q;},&q;roomSettings&q;:{&q;publishRoomId&q;:0,&q;logoUrl&q;:&q;https://cdn.filestackcontent.com/GtKTfRGfTbivkX2soNno&q;,&q;mailLogoUrl&q;:&q;https://cdn.filestackcontent.com/GtKTfRGfTbivkX2soNno&q;,&q;favIconUrl&q;:&q;https://cdn.filestackcontent.com/YWpsS0C7Sl62uteK49TA&q;,&q;accentColor&q;:&q;#c51162&q;,&q;headerTitle&q;:&q;Välkommen till SwedenBIOs pressrum&q;,&q;headerSubtitle&q;:&q;&q;,&q;headerImageUrl&q;:&q;https://cdn.filestackcontent.com/yPiTBxBMRcGyyMzTJiRR&q;,&q;headerBlurLevel&q;:0,&q;headerTextColor&q;:&q;rgb(255,255,255)&q;,&q;headerBackgroundColor&q;:&q;rgba(0,0,0,0.07)&q;,&q;headerFollowButtonBackgroundColor&q;:&q;rgb(255,187,31)&q;,&q;headerFollowButtonTextColor&q;:&q;rgb(255,255,255)&q;,&q;headerWidgetActive&q;:null,&q;headerWidgetSpeed&q;:null,&q;headerWidgetAutoplay&q;:null,&q;roomMenuEnabledHome&q;:true,&q;roomMenuEnabledNews&q;:false,&q;roomMenuEnabledContent&q;:true,&q;roomMenuEnabledContacts&q;:true,&q;customMenuItemUrl1&q;:&q;https://swedenbio.se&q;,&q;customMenuItemName1&q;:&q;swedenbio.se&q;,&q;customMenuItemUrl2&q;:null,&q;customMenuItemName2&q;:null,&q;customMenuItemUrl3&q;:null,&q;customMenuItemName3&q;:null,&q;customMenuItemUrl4&q;:null,&q;customMenuItemName4&q;:null,&q;customMenuItemUrl5&q;:null,&q;customMenuItemName5&q;:null,&q;customMenuItemUrl6&q;:null,&q;customMenuItemName6&q;:null,&q;customMenuItemUrl7&q;:null,&q;customMenuItemName7&q;:null,&q;customMenuItemUrl8&q;:null,&q;customMenuItemName8&q;:null,&q;customCss&q;:&q;\nh1,h2,h3,h4,h5,h6{ font-family: &s;Inter&s;}\nbody{ font-family: &s;Inter&s;}\n.btn{ font-family: &s;Inter&s;}\n\n.powered-by-footer {\n background-color: rgb(252,252,253);\n color: rgb(179,179,179);\n}\n\n.powered-by-footer a {\n color:rgb(179,179,179);\n}\n\n.navbar .navbar-brand img {\n height: 57px;\n}\n\n.navbar .navbar-brand {\n top: 9px;\n}\n\n.navbar {\n background-color: rgb(252,252,253)!important; \n}\n\n.navbar-light .navbar-nav .nav-link {\n color:rgb(179,179,179); \n}&q;,&q;headingFontFamily&q;:{&q;type&q;:&q;typeKitFont&q;,&q;fontName&q;:&q;Abril Text&q;,&q;externalId&q;:&q;gjst&q;,&q;cssSelector&q;:&q;abril-text-1&q;},&q;paragraphFontFamily&q;:{&q;type&q;:&q;typeKitFont&q;,&q;fontName&q;:&q;Proxima Nova&q;,&q;externalId&q;:&q;vcsm&q;,&q;cssSelector&q;:&q;proxima-nova-1&q;},&q;typeKitId&q;:&q;ttf3esh&q;,&q;logoHref&q;:&q;&q;},&q;publishRoomLabel&q;:{&q;language&q;:&q;english&q;,&q;publishRoomId&q;:20701,&q;pressRelease&q;:&q;Pressmeddelande&q;,&q;pressReleases&q;:&q;Pressmeddelanden&q;,&q;regulatoryPressRelease&q;:&q;Regulatory press release&q;,&q;regulatoryPressReleases&q;:&q;Regulatory press releases&q;,&q;readMore&q;:&q;Läs mer&q;,&q;readAllPressReleases&q;:&q;Läs alla nyheter&q;,&q;about&q;:&q;Om&q;,&q;home&q;:&q;Hem&q;,&q;content&q;:&q;Pressmaterial&q;,&q;contacts&q;:&q;Kontaktpersoner&q;,&q;readAllBlogPosts&q;:&q;Läs alla bloggposter&q;,&q;viewMore&q;:&q;Visa fler&q;,&q;view&q;:&q;Visa&q;,&q;news&q;:&q;Nyheter&q;,&q;blogPosts&q;:&q;Nyhetsbrev&q;,&q;blogPost&q;:&q;Nyhetsbrev&q;,&q;newsPost&q;:&q;Nyhet&q;,&q;newsPosts&q;:&q;Nyheter&q;,&q;latestNews&q;:&q;Senaste nyheterna&q;,&q;topics&q;:&q;Ämnen&q;,&q;newsTypes&q;:&q;Nyhetstyper&q;,&q;noMoreItems&q;:&q;Inga fler nyheter&q;,&q;relatedLinks&q;:&q;Relaterade länkar&q;,&q;relatedFiles&q;:&q;Relaterad media&q;,&q;relatedPressKits&q;:&q;Relaterade presskit&q;,&q;relatedPosts&q;:&q;Relaterade nyheter&q;,&q;download&q;:&q;Ladda ned&q;,&q;fileType&q;:&q;Filtyp&q;,&q;license&q;:&q;Licens&q;,&q;size&q;:&q;Storlek&q;,&q;follow&q;:&q;Följ&q;,&q;name&q;:&q;Namn&q;,&q;yourEmailAddress&q;:&q;Din email adress&q;,&q;privacyConcent&q;:&q;Jag godkänner att min personliga uppgifter hanteras i enlighet med Integritetspolicyn&q;,&q;privacyText&q;:&q;Genom att välja att följa nyhetsrummet kommer dina personuppgifter behandlas av ägaren till nyhetsrummet. Du kommer periodvis att få nyheter som avsändaren bedömer vara av intresse för dig skickat till din e-post.\n &q;,&q;enterMailText&q;:&q;Skriv in din email adress och namn för att börja få nyheter från&q;,&q;sendingConfirmMailText&q;:&q;Vi skickar ett bekräftelse mail till din epost&q;,&q;verifyMailText&q;:&q;Kolla efter bekräftelse mailet i din inbox och klicka på verfiera länken.&q;,&q;mailShareTitle&q;:&q;Dela detta inlägg på sociala medier&q;,&q;allTopics&q;:&q;All topics&q;,&q;allYears&q;:&q;All years&q;,&q;allMonths&q;:&q;All months&q;,&q;january&q;:&q;January&q;,&q;february&q;:&q;February&q;,&q;march&q;:&q;March&q;,&q;april&q;:&q;April&q;,&q;may&q;:&q;May&q;,&q;june&q;:&q;June&q;,&q;july&q;:&q;July&q;,&q;august&q;:&q;August&q;,&q;september&q;:&q;September&q;,&q;october&q;:&q;October&q;,&q;november&q;:&q;November&q;,&q;december&q;:&q;December&q;,&q;noItemsExist&q;:&q;There are no news posts that match your filter or search.&q;,&q;emailIsRequired&q;:&q;Email is required&q;,&q;invalidEmail&q;:&q;Invalid email&q;,&q;unsubscribePrivacyPolicy&q;:&q;You may unsubscribe from these communications at any time. For more information, please read our&q;,&q;privacyPolicy&q;:&q;Privacy Policy&q;,&q;tickToFollow&q;:&q;You need to tick this box to be able to follow newsroom.&q;,&q;close&q;:&q;Close&q;,&q;cookieConsentDescription&q;:&q;Notified&s;s websites use cookies to ensure that we give you the best experience when you visit our websites or use our Services. If you continue without changing your browser settings, you are agreeing to our use of cookies. Find out more by reading our &l;a href&s;https://www.intrado.com/en/legal-privacy&s;&g;privacy policy&l;/a&g;&q;,&q;accept&q;:&q;Accept&q;,&q;reject&q;:&q;Reject&q;,&q;photographer&q;:&q;Photographer&q;},&q;customFonts&q;:{&q;id&q;:1453,&q;fontName&q;:&q;Inter&q;,&q;eotUrl&q;:&q;&q;,&q;woffUrl&q;:&q;&q;,&q;woff2Url&q;:&q;&q;,&q;ttfUrl&q;:&q;https://cdn.filestackcontent.com/Vvkc97QSLC9JF4JP6vWg&q;,&q;otfUrl&q;:&q;&q;},&q;gnwPressReleaseFeedUrl&q;:null,&q;hasRegulatoryPressReleases&q;:false},&q;frontPageKey&q;:{&q;featuredItems&q;:{&q;id&q;:67304,&q;title&q;:&q;From addressing innovation and funding to state-of-the-art patient care, SwedenBIO wraps up another highly successful NLSDays event&q;,&q;summary&q;:&q;\n The seventh NLSDays united 1240 delegates from a record number of organizations across the global life science industry, to focus on improving healthcare technologies and delivery in the Nordics.This year saw an extended first day with a number of satellite events, including educational sessions on clinical development, funding for SMEs, and advancing ATMPs into the clinic. There was also a series of pitches to showcase the best of Swedish and Danish life science from Medicon &q;,&q;description&q;:&q;\n &l;div&g;&l;div&g;&l;p&g;&l;strong&g;The seventh NLSDays united 1240 delegates from a record number of organizations across the global life science industry, to focus on improving healthcare technologies and delivery in the Nordics.&l;/strong&g;&l;/p&g;&l;p&g;&l;strong&g;&l;/strong&g;This year saw an extended first day with a number of satellite events, including educational sessions on clinical development, funding for SMEs, and advancing ATMPs into the clinic. There was also a series of pitches to showcase the best of Swedish and Danish life science from Medicon Valley, as well as the inaugural Nordic Life Science Awards.&l;/p&g;&l;p&g;Day 2 kicked off with the Opening Plenary session, which was delivered by Niklas Johansson, State Secretary to the Minister for Foreign Trade. He discussed the Swedish Government’s commitment to innovation and the need for the industry to work together. Co-creation and collaboration continued to be common threads during many of the day’s panel discussions and seminars. Financing and investment were also strong themes – from feeding innovation, which always needs funding, to health economics and preparing for an IPO.&l;/p&g;&l;p&g;The collaboration theme continued during day 3’s panel sessions and seminars, which focused on metabolic diseases, oncology and individualized medicine. Discussions moved on to address how organizations across the Nordic ecosystem can work together to leverage local strongholds, and take a globally leading position for addressing future healthcare challenges.&l;/p&g;&l;p&g;The event also featured 46 company presentations with updates from organizations of all sizes, and 2 750 partnering meetings for delegates throughout the event. &l;/p&g;&l;p&g;Olivier Duchamp, Managing Director, NLSDays wrapped up the show:&l;/p&g;&l;p&g;– We would like to thank our regional co-hosts, our Nordic consortium partners, sponsors, exhibitions, presenters, speakers and delegates for making this such a great event. We are also happy to be back in Malmö for the next two upcoming years. This is really a hotbed for life science and business partnerships. See you again next year on September 8-10!&l;/p&g;&l;p&g;&l;strong&g;NLSDays in brief&l;/strong&g;&l;/p&g;&l;p&g;&l;strong&g;&l;/strong&g;&l;/p&g;&l;p&g;Companies/organizations: 790&l;/p&g;&l;p&g;Registered delegates: 1 240&l;/p&g;&l;p&g;Meetings scheduled: 2 750&l;/p&g;&l;p&g;&l;strong&g;Malmö again next year&l;/strong&g;&l;/p&g;&l;p&g;&l;strong&g;&l;/strong&g;&l;/p&g;&l;p&g;NLSDays will return to MalmöMässan next year, join us from 8-10 September 2020.&l;/p&g;&l;p&g;&l;strong&g;Contacts &l;/strong&g;&l;/p&g;&l;p&g;&l;em&g;NLSDays&l;br&g;&l;/em&g;Olivier DuChamp&l;br&g;Managing Director, NLSDays&l;br&g;&l;a href\&q;mailto:olivier.duchamp@swedenbio.se\&q; rel\&q;nofollow\&q;&g;olivier.duchamp@swedenbio.se&l;br&g;&l;/a&g;+33 (0) 467 912 113&l;/p&g;&l;p&g;&l;em&g;Editorial enquiries&l;br&g;&l;/em&g;Kate Whelan&l;br&g;Notch Communications&l;br&g;&l;a href\&q;mailto:Kate.whelan@notchcommunications.se\&q; rel\&q;nofollow\&q;&g;Kate.whelan@notchcommunications.se&l;br&g;&l;/a&g;+46 (0) 702 381 149&l;/p&g;&l;/div&g;\n&l;div&g;&l;p&g;&l;em&g;&l;strong&g;About NLSDays&l;/strong&g;&l;/em&g;&l;/p&g;&l;p&g;&l;em&g;NLSDays, which is organized by SwedenBIO, has grown rapidly since its launch in 2012 and has developed into the largest Nordic partnering conference for the international life science industry. &l;/em&g;&l;/p&g;&l;p&g;&l;em&g;&l;strong&g;About SwedenBIO&l;/strong&g;&l;/em&g;&l;/p&g;&l;p&g;&l;em&g;SwedenBIO, the trade association for the Swedish life science sector has&l;a href\&q;http://swedenbio.se/vara-medlemmar/vara-medlemmar/\&q; rel\&q;nofollow\&q;&g; more than 260 members&l;/a&g; operating across all sub-sectors from pharmaceutical, biotechnology, medical technology to diagnostics. SwedenBIO serves to the benefit the entire life science industry in Sweden and is a member-driven, private, non-profit organization. The main objective is to contribute to improving the conditions for the life science industry for the benefit of industry growth and business development. Sweden’s life science industry accounts for 20% of Sweden&s;s net exports.&l;/em&g;&l;/p&g;&l;/div&g;&l;/div&g;\n\n &q;,&q;companyAbout&q;:&q;&l;p style\&q;white-space: pre-wrap; font-size: 17px; margin-bottom: 0; font-style: italic;\&q;&g;Working for a successful life science industry \r\n\r\nThe Life Science Industry has improved the lives of millions of people, has created enormous values and is one of the most beneficial industries to our society.\r\n\r\nSwedenBIO is one of Europe´s largest industry organisations representing more than 180 exciting member companies in Sweden. SwedenBIO is the industry´s only national organisation with a mission to promote an environment bringing success and growth to the entire Swedish Life Science Industry. \r\n\r\nJoin and follow us:\r\nTwitter \r\nLinked In\r\nYoutube&l;/p&g;&q;,&q;canonicalUrl&q;:null,&q;imageUrl&q;:&q;https://cdn.filestackcontent.com/2sqaUuNBS16JcruOC3Iv&q;,&q;imageDescription&q;:null,&q;imageAlt&q;:null,&q;published&q;:&q;2019-09-12T17:29:00.000Z&q;,&q;created&q;:&q;2019-09-12T17:29:00&q;,&q;sluggedName&q;:&q;from-addressing-innovation-and-funding-to-sta&q;,&q;isFeatured&q;:true,&q;language&q;:&q;en&q;,&q;status&q;:&q;active&q;,&q;type&q;:&q;pressRelease&q;,&q;contacts&q;:,&q;topics&q;:,&q;relatedContent&q;:,&q;publishUrl&q;:&q;press.swedenbio.se/posts/pressreleases/from-addressing-innovation-and-funding-to-sta&q;},&q;widgets&q;:{&q;id&q;:26065,&q;publishRoomId&q;:20701,&q;title&q;:&q;Utvalda poster&q;,&q;widgetType&q;:&q;featuredItemsWidget&q;,&q;tagWidgetRenderType&q;:null,&q;tagWidgetItemCount&q;:null,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:false,&q;featuredItemsWidgetSpeed&q;:5,&q;featuredItemsWidgetAutoplay&q;:true,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:0,&q;isEnabled&q;:false,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:26066,&q;publishRoomId&q;:20701,&q;title&q;:&q;Pressmeddelanden&q;,&q;widgetType&q;:&q;itemsWidget&q;,&q;tagWidgetRenderType&q;:null,&q;tagWidgetItemCount&q;:null,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:false,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:1,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:&q;pressRelease&q;,&q;news&q;,&q;itemWidgetItemCount&q;:4,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:26067,&q;publishRoomId&q;:20701,&q;title&q;:&q;Om oss i media&q;,&q;widgetType&q;:&q;tagBasedItemWidget&q;,&q;tagWidgetRenderType&q;:&q;list&q;,&q;tagWidgetItemCount&q;:6,&q;tagWidgetTagIds&q;:31409,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:true,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:4,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:26068,&q;publishRoomId&q;:20701,&q;title&q;:&q;Artiklar från Nyhetsbrev&q;,&q;widgetType&q;:&q;itemsWidget&q;,&q;tagWidgetRenderType&q;:null,&q;tagWidgetItemCount&q;:null,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:false,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:3,&q;isEnabled&q;:false,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:&q;blog&q;,&q;itemWidgetItemCount&q;:6,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:26069,&q;publishRoomId&q;:20701,&q;title&q;:&q;Om SwedenBIO&q;,&q;widgetType&q;:&q;htmlWidget&q;,&q;tagWidgetRenderType&q;:null,&q;tagWidgetItemCount&q;:null,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:false,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:&q;&l;p&g;Branschorganisationen SwedenBIO arbetar f&a;ouml;r en konkurrenskraftig life science-sektor i Sverige. Vi g&a;ouml;r det genom att skapa effektiva kontaktytor mellan sektorns olika akt&a;ouml;rer, genom att bygga kunskap och genom att ge branschen en stark r&a;ouml;st i samh&a;auml;llsdebatten.&l;/p&g;\n&l;p&g;V&a;aring;ra &l;a href\&q;https://shared.outlook.inky.com/link?domainswedenbio.se&a;amp;teyJ0eXAiOiJKV1QiLCJhbGciOiJFUzI1NiJ9.eJxlkNFrwjAQxv-XPGutXfuwgqA4HI41ItR1LYJcmhtpTVKXxLp17H9f-ja2t7v7-N19330Rh6AaTlLSaGeAd2QyVmg0SJK-gbQ4Iehl3dSdxECAHjq9tDfkqFnTBRY9MfJ_RlfjeSKcu6TH2XH2Wz3OejAwVcglKgXmf-_53YGk-irlhDhhENxJYo9-Zej9jeegSMJabc7s8_6dRUIwlYhndZFMU8maeVu-PtmqSFY8ehn4OmlZFPZVsY-rfBvRgZ-ztg5ptP_I1D6mD3VStdu7sshC-rgR5XDus_yQ7PJyvssPN7qOY7paLMZYFs0JFTTyBJwbtNZ7aTv_Fg1Bi9qintZgJOrlDa0L6k6R7x_YAHpR.MEQCIDp8co2SyuJQvXUv-cwts0BDdB6OFWCzYUokISyCrOVQAiB7WW4Wp_JnXuW9W-EKjapnkQrdjEl2FfKNsdAxa8-lBA\&q; target\&q;_blank\&q; rel\&q;noopener noreferrer\&q; data-auth\&q;NotApplicable\&q;&g;mer &a;auml;n 300 medlemsf&a;ouml;retag&l;/a&g;&a;nbsp;har totalt 20 000 anst&a;auml;llda och bedriver verksamhet inom l&a;auml;kemedelsutveckling, bioteknik, medicinteknik och diagnostik eller &a;auml;r experter inom bland annat aff&a;auml;rsutveckling, finansiering, immaterialr&a;auml;tt och juridik.&l;/p&g;&q;,&q;sortOrder&q;:6,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:26070,&q;publishRoomId&q;:20701,&q;title&q;:&q;Kontaktpersoner&q;,&q;widgetType&q;:&q;contactWidget&q;,&q;tagWidgetRenderType&q;:null,&q;tagWidgetItemCount&q;:null,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:false,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:7,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:43661,&q;publishRoomId&q;:20701,&q;title&q;:&q;Branschnyheter&q;,&q;widgetType&q;:&q;tagBasedItemWidget&q;,&q;tagWidgetRenderType&q;:&q;masonry&q;,&q;tagWidgetItemCount&q;:9,&q;tagWidgetTagIds&q;:,&q;tagWidgetSearchProfileIds&q;:91778,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:true,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:5,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},{&q;id&q;:55755,&q;publishRoomId&q;:20701,&q;title&q;:&q;Opinion &a; debatt&q;,&q;widgetType&q;:&q;tagBasedItemWidget&q;,&q;tagWidgetRenderType&q;:&q;masonry&q;,&q;tagWidgetItemCount&q;:6,&q;tagWidgetTagIds&q;:46008,&q;tagWidgetSearchProfileIds&q;:,&q;tagWidgetSearchProfilePostTypes&q;:,&q;tagWidgetLoadMore&q;:true,&q;featuredItemsWidgetSpeed&q;:null,&q;featuredItemsWidgetAutoplay&q;:false,&q;htmlWidgetHtml&q;:null,&q;sortOrder&q;:2,&q;isEnabled&q;:true,&q;itemWidgetRenderType&q;:&q;box&q;,&q;itemWidgetItemTypes&q;:,&q;itemWidgetItemCount&q;:0,&q;itemWidgetTopicIds&q;:,&q;itemWidgetLoadMore&q;:false},&q;contacts&q;:{&q;id&q;:42857,&q;name&q;:&q;Jessica Martinsson&q;,&q;sortOrder&q;:0,&q;title&q;:&q;CEO &a; Director General&q;,&q;description&q;:null,&q;picture&q;:&q;https://cdn.filestackcontent.com/auto_image/YKJvWojiSRCVT7SSDE1p&q;,&q;email&q;:&q;jessica.martinsson@swedenbio.se&q;,&q;phone&q;:null,&q;phone2&q;:null,&q;twitterHandle&q;:null,&q;instagramUsername&q;:null,&q;linkedInUsername&q;:&q;https://www.linkedin.com/in/jessica-martinsson/&q;,&q;enabledInNewsroom&q;:true},{&q;id&q;:47738,&q;name&q;:&q;Afram Yakoub&q;,&q;sortOrder&q;:0,&q;title&q;:&q;Communications Manager&q;,&q;description&q;:null,&q;picture&q;:&q;https://cdn.filestackcontent.com/auto_image/iaWDsiQkmuCYjVlwCjFw&q;,&q;email&q;:&q;afram.yakoub@swedenbio.se&q;,&q;phone&q;:&q;+46 (0) 73 141 17 89&q;,&q;phone2&q;:null,&q;twitterHandle&q;:null,&q;instagramUsername&q;:null,&q;linkedInUsername&q;:null,&q;enabledInNewsroom&q;:true}},&q;itemsKey-26066&q;:{&q;items&q;:{&q;id&q;:317015,&q;title&q;:&q;MyCural Therapeutics wins Nordic Star Pitch Competition&q;,&q;summary&q;:&q;MyCural Therapeutics awed the audience at Nordic Life Science Days and took home the prize at the premier Nordic Life Science partnering conference. &q;,&q;description&q;:&q;&l;p&g;&l;strong&g;MyCural Therapeutics awed the audience at Nordic Life Science Days and took home the prize at the premier Nordic Life Science partnering conference.&l;br /&g;&l;/strong&g;&l;/p&g;\n&l;p&g;As the premier event dedicated to Nordic life science innovation, NLSDays provides a platform to raise the visibility of early-stage companies and founders, and this year in Malm&a;ouml; two awards in two different competitions were handed out, the Nordic Star pitch competition and the Innovation Poster exhibition.&l;/p&g;\n&l;p&g;&l;strong&g;Nordic Star Pitch Competition&l;br /&g;&l;/strong&g;The Nordic Star pitch competition welcomed 20 SMEs from across the Nordics, which each gave a four-minute pitch on-stage to the jury and an audience of investors.&l;/p&g;\n&l;p&g;The Swedish life science start-up&l;strong&g;&a;nbsp;MyCural Therapeutics&l;/strong&g;&a;nbsp;took home the&a;nbsp;&l;em&g;NLSDays Nordic Star 2024 Award&l;/em&g;, consisting of a 10,000 EUR cash prize and two tickets to next year&a;rsquo;s event. Dr Alina Castell, the CEO of the young company accepted the prize onstage.&l;br /&g;MyCural Therapeutics is a start-up life science company founded by cancer researchers from Karolinska Institutet, Link&a;ouml;ping University and Uppsala University.&l;/p&g;\n&l;p&g;&a;rdquo;I am surprised by the win because I don&s;t think we are that close to having a product yet, but I believe I put together a pitch that answered most of the questions, and I think that was the key. It also certainly helps that I have spent two years practicing pitching,\&q; said Dr. Alina Catell, CEO of MyCural Therapeutics.&l;/p&g;\n&l;p&g;&a;rdquo;The winning company is working on a well validated clinical unmet need that also harbors significant commercial potential. As an investor, we are always on the look for innovative approaches with platform potential, and that is what we see in MyCural&a;rdquo;, commented Dr. Sara Kangaspeska, Investment Director at Innovestor Life Science &a;amp; Health Fund and member of the jury.&l;/p&g;\n&l;p&g;The pitch competition jury consisted of&a;nbsp;&l;strong&g;Mandeep Dhillon&l;/strong&g;, Global Scientific Sourcing, Strategy &a;amp; Operations, Johnson &a;amp; Johnson, Dr. &l;strong&g;Sara Kangaspeska&l;/strong&g;, Investment Director at Innovestor Life Science &a;amp; Health Fund, Dr. &l;strong&g;Markus Dietrich&l;/strong&g;, Senior Investment Associate, Hadean Ventures, I&l;strong&g;nka Mero&l;/strong&g;, Founder &a;amp; Managing Partner at Voima Ventures, Dr. &l;strong&g;Chlo&a;eacute; Lepretre&l;/strong&g;, Head of Global R&a;amp;D Search and Evaluation at Servier, Dr. &l;strong&g;Lovisa Backemar&l;/strong&g;, Principal at Eir Ventures, Dr. &l;strong&g;Marjo Puumalainen&l;/strong&g;, International Director at SwedenBIO and Program Director NLSDays.&l;/p&g;\n&l;p&g;The Nordic Star pitch competition was sponsored by Johnson &a;amp; Johnson, Innovestor, and SwedenBIO&l;/p&g;\n&l;p&g;&l;strong&g;Innovation Poster Exhibition winner&l;/strong&g;&l;/p&g;\n&l;p&g;22 academic researchers and SME:s from Nordic academia and industry were selected to present posters outlining a project with commercial potential.&l;br /&g;&l;br /&g;&l;strong&g;Dr Giacomo Roman from &l;/strong&g;Oslo University Hospital, Norway&l;strong&g;, &l;/strong&g;won the competition with his poster: &a;ldquo;Autologous cell-based therapy for coagulation factor deficiency&a;rdquo;. &l;br /&g;&l;br /&g;&a;rdquo;I think the novelty of the approach, particularly the tremendous therapeutic (as well as drug screening and disease modelling) potential of the three-dimensional liver organoids has been the key that attracted participants&a;rsquo; attention&a;rdquo;, commented Dr Roman.&l;/p&g;\n&l;p&g;&l;strong&g;NLSDays 2025&l;br /&g;&l;/strong&g;Next year&s;s&a;nbsp;&l;em&g;NLSDays&l;/em&g;&a;nbsp;is taking place in Gothenburg, Sweden 13&a;ndash;14 October.&l;/p&g;\n&l;div align\&q;center\&q;&g;&l;hr align\&q;center\&q; size\&q;0\&q; width\&q;100%\&q; /&g;&l;/div&g;\n&l;p&g;&l;strong&g;About SwedenBIO&l;/strong&g;&l;/p&g;\n&l;p&g;&a;ndash;&a;ndash; About Nordic Life Science Days &a;ndash;&a;ndash; Nordic Life Science Days 2023 took place at Bella Center in Copenhagen, Denmark, on November 29-30. NLSDays is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science and created a unique place to do business. NLSDays attracts leading decision makers from biotech, pharma and medtech, as well as finance, research, policy and regulatory authorities. NLSDays is owned and organized by SwedenBIO. &l;a href\&q;https://newsroom.notified.com/www.nlsdays.com\&q;&g;www.nlsdays.com&l;/a&g; &l;br /&g;&l;br /&g;&a;ndash;&a;ndash; About SwedenBIO &a;ndash;&a;ndash; SwedenBIO is the national association for the Swedish life science industry, representing the sector both domestically and globally. Sweden has a vibrant, innovative life science industry, strong academia, and world-leading infrastructure for research. SwedenBIO&a;rsquo;s 340+ members are companies within pharma, biotech, diagnostics and medtech, and comprise the entire range from small start-ups to SMEs and large enterprises. NLSDays is SwedenBIO&a;rsquo;s flagship event. &l;a href\&q;https://newsroom.notified.com/www.swedenbio.se\&q;&g;www.swedenbio.se&l;/a&g;&l;/p&g;&q;,&q;companyAbout&q;:&q;&l;p&g;Branschorganisationen SwedenBIO arbetar f&a;ouml;r en konkurrenskraftig life science-sektor i Sverige. Vi g&a;ouml;r det genom att skapa effektiva kontaktytor mellan sektorns olika akt&a;ouml;rer, genom att bygga kunskap och genom att ge branschen en stark r&a;ouml;st i samh&a;auml;llsdebatten.&a;nbsp; &a;nbsp;V&a;aring;ra mer &a;auml;n 330 medlemsf&a;ouml;retag bedriver verksamhet inom l&a;auml;kemedelsutveckling, bioteknik, medicinteknik och diagnostik eller &a;auml;r experter inom bland annat aff&a;auml;rsutveckling, finansiering, immaterialr&a;auml;tt och juridik.&l;/p&g;&q;,&q;canonicalUrl&q;:null,&q;imageUrl&q;:&q;https://cdn.filestackcontent.com/auto_image/1OgEpl9lTISQlqmUHpCs&q;,&q;imageDescription&q;:&q;MyCural Therapeutics won the Nordic Star pitch competition at NLSDays in Malmö. &q;,&q;imageAlt&q;:&q;MyCural Therapeutics won the Nordic Star pitch competition at NLSDays in Malmö. &q;,&q;published&q;:&q;2024-09-20T07:31:37.308Z&q;,&q;created&q;:&q;2024-09-20T07:31:37.308&q;,&q;sluggedName&q;:&q;mycural-therapeutics-wins-nordic-star-pitch-c&q;,&q;isFeatured&q;:false,&q;language&q;:&q;en&q;,&q;status&q;:&q;active&q;,&q;type&q;:&q;pressRelease&q;,&q;contacts&q;:,&q;topics&q;:,&q;relatedContent&q;:,&q;publishUrl&q;:&q;press.swedenbio.se/posts/pressreleases/mycural-therapeutics-wins-nordic-star-pitch-c&q;},{&q;id&q;:315562,&q;title&q;:&q;NLSDays: Premier Nordic Life Science Event Attracts Investors to Malmö&q;,&q;summary&q;:&q;NLSDays, the premier Nordic life science event, is returning to Malmö, Sweden, on September 18-19. The international conference is set to draw a di...&q;,&q;description&q;:&q;&l;p&g;&l;strong&g;NLSDays, the premier Nordic life science event, is returning to Malm&a;ouml;, Sweden, on September 18-19. The international conference is set to draw a diverse group of investors, pharmaceutical companies, and life science leaders from the Nordics and beyond, highlighting the region&a;rsquo;s role as a global life science hub.&l;/strong&g;&l;/p&g;\n&l;p&g;Nordic Life Science Days (NLSDays) will this year be held in Malm&a;ouml;, Sweden, on September 18-19, once again welcoming industry delegates, exhibitors, presenters, and investors from across the Nordics and the world.&l;/p&g;\n&l;p&g;&a;ldquo;The Nordic region has truly become a global hotspot for life sciences, and the significant growth of this event has sparked numerous collaborations and acquisitions. We take pride in fostering stronger connections within the Nordic countries while also opening the region to international opportunities,&a;rdquo; says Jessica Martinsson, CEO of SwedenBIO, the industry association that owns and organizes NLSDays.&l;/p&g;\n&l;p&g;Since its inception in 2013, NLSDays has steadily expanded, attracting a diverse range of actors from all parts of the life science ecosystem, both from the Nordics and beyond, who are eager to engage with the region&a;rsquo;s vibrant life science industry.&l;/p&g;\n&l;p&g;&a;ldquo;The Nordic life science industry is experiencing rapid growth, making it clear that we need a dedicated space to connect and showcase Nordic companies to international investors and pharmaceutical giants. NLSDays offers just that, and the high number of returning and new delegates each year is a testament to the event&a;rsquo;s ongoing success,&a;rdquo; says Marjo Puumalainen, Program Manager of NLSDays.&l;/p&g;\n&l;p&g;&l;strong&g;Key highlights of the conference include:&l;/strong&g; &l;br /&g;&a;bull; &l;strong&g;Five super sessions&l;/strong&g; on the latest trends in life science, featuring panels of seasoned experts and moderators.&l;/p&g;\n&l;p&g;&a;bull; &l;strong&g;The Nordic Star Pitch Competition&l;/strong&g;, where 20 up-and-coming Nordic SMEs will pitch to investors and compete for a prize.&l;/p&g;\n&l;p&g;&a;bull; &l;strong&g;Lunch workshops&l;/strong&g; and &l;strong&g;company presentations&l;/strong&g;.&l;/p&g;\n&l;p&g;&a;bull; &l;strong&g;A poster session&l;/strong&g; showcasing academic projects with commercial potential.&l;/p&g;\n&l;p&g;&a;bull; &l;strong&g;A sold-out exhibition area&l;/strong&g;, including country and regional pavilions.&l;/p&g;\n&l;p&g;&a;bull; &l;strong&g;Regional and country presentations&l;/strong&g; from G&a;ouml;teborg, Sk&a;aring;ne, the Netherlands and France.&l;/p&g;\n&l;p&g;&l;strong&g;For journalists&l;/strong&g;&l;/p&g;\n&l;p&g;Journalists from established news outlets or life science publications are invited to attend NLSDays free of charge but must register in advance. Please contact Afram Yakoub, Communications Manager, to apply for a press pass: afram.yakoub@swedenbio.se&l;/p&g;&q;,&q;companyAbout&q;:&q;&l;p&g;Branschorganisationen SwedenBIO arbetar f&a;ouml;r en konkurrenskraftig life science-sektor i Sverige. Vi g&a;ouml;r det genom att skapa effektiva kontaktytor mellan sektorns olika akt&a;ouml;rer, genom att bygga kunskap och genom att ge branschen en stark r&a;ouml;st i samh&a;auml;llsdebatten.&a;nbsp; &a;nbsp;V&a;aring;ra mer &a;auml;n 330 medlemsf&a;ouml;retag bedriver verksamhet inom l&a;auml;kemedelsutveckling, bioteknik, medicinteknik och diagnostik eller &a;auml;r experter inom bland annat aff&a;auml;rsutveckling, finansiering, immaterialr&a;auml;tt och juridik.&l;/p&g;&q;,&q;canonicalUrl&q;:null,&q;imageUrl&q;:&q;https://cdn.filestackcontent.com/auto_image/MlaHlyKRwkWEkwKQANyA&q;,&q;imageDescription&q;:&q;NLSDays, the premier Nordic life science conference &q;,&q;imageAlt&q;:&q;NLSDays, the premier Nordic life science conference &q;,&q;published&q;:&q;2024-09-11T07:30:15.583Z&q;,&q;created&q;:&q;2024-09-11T07:30:15.583&q;,&q;sluggedName&q;:&q;nlsdays-premier-nordic-life-science-event-att&q;,&q;isFeatured&q;:false,&q;language&q;:&q;en&q;,&q;status&q;:&q;active&q;,&q;type&q;:&q;pressRelease&q;,&q;contacts&q;:,&q;topics&q;:,&q;relatedContent&q;:,&q;publishUrl&q;:&q;press.swedenbio.se/posts/pressreleases/nlsdays-premier-nordic-life-science-event-att&q;},{&q;id&q;:312395,&q;title&q;:&q;Swedish and Danish Life Science experiencing substantial growth &q;,&q;summary&q;:&q;The life science sectors in Sweden and Denmark are experiencing impressive growth, solidifying the position of the Nordic region as a key player in...&q;,&q;description&q;:&q;&l;h5&g;The life science sectors in Sweden and Denmark are experiencing impressive growth, solidifying the position of the Nordic region as a key player in the global industry.&l;/h5&g;\n&l;p&g;The Nordics have long been recognized as a hub of research and innovation, so it&a;rsquo;s little surprise that the life sciences&a;mdash;one of the most research-intensive sectors&a;mdash;are seeing substantial growth in this region. Pharmaceuticals now account for nearly ten percent of Sweden&a;rsquo;s total exports, with an impressive 180 percent growth over the past decade (1). In neighboring Denmark, the pharma industry delivers 19 percent of all exports, with an astonishing 227 percent increase since 2008 (2).&l;/p&g;\n&l;h5&g;Differences and similiarities&l;br /&g;&l;span style\&q;font-size: 13pt;\&q;&g;Denmark&a;rsquo;s life science growth is largely driven by the success of Novo Nordisk and its diabetes and weight-loss products. Meanwhile, Sweden&a;rsquo;s progress has been fueled by a more diverse roster of mainly small- and medium size research and production companies as well as bold start-ups, many of which have achieved notable success, such as Calliditas, Bioarctic and Orexo to name a few.&l;/span&g;&l;/h5&g;\n&l;p&g;The number of Swedish life science companies doubled between 2010 and 2020, reaching 3 300, and the growth shows no sign of slowing. The latest data from 2023 estimates the presence of around 4,000 companies (3). The life science sector is now increasingly regarded as one of Sweden&a;rsquo;s key industries, alongside steel, forestry, and automotive, employing approximately 50,000 people&a;mdash;many with advanced degrees.&l;/p&g;\n&l;h5&g;Nordic collaboration key to success&l;br /&g;&l;span style\&q;font-size: 13pt;\&q;&g;Marjo Puumalainen, Program Director of Nordic Life Science Days, the largest life science conference dedicated to the Nordics, has witnessed this remarkable growth firsthand. &a;ldquo;The Nordic life science industry is experiencing rapid expansion,&a;rdquo; she explains. &a;ldquo;It&a;rsquo;s clear we need a dedicated space to connect and showcase Nordic companies to international investors and pharmaceutical giants.&a;rdquo; This growth is evident on the exhibition floor during NLSDays, as the conference has expanded each year since its inception in 2013, becoming the premier partnering event for companies across the Nordics. It also attracts participants from Europe and beyond, all eager to forge new business connections.&l;/span&g;&l;/h5&g;\n&l;p&g;International competition, however, remains fierce, with other regions vying for the attention of investors, talent, and big pharma. Puumalainen believes that greater Nordic cooperation is essential for competing on the global stage and solidifying recent gains. &a;ldquo;In such a competitive global landscape, our smaller Nordic countries must unite and strategize wisely. By continuing to collaborate effectively, the future of Nordic life science holds tremendous promise,&a;rdquo; she says.&l;br /&g;&l;br /&g;Notes&l;br /&g;1:&a;nbsp;&l;a href\&q;https://www.dn.se/ekonomi/lakemedelsexport-fortsatter-att-boosta-svensk-ekonomi/\&q; target\&q;_blank\&q; rel\&q;noreferrer noopener\&q;&g;https://www.dn.se/ekonomi/lakemedelsexport-fortsatter-att-boosta-svensk-ekonomi/&l;/a&g;&l;br /&g;2:&a;nbsp;&l;a href\&q;https://www.newsoresund.se/svensk-och-dansk-life-science-industri-allt-viktigare-for-landernas-ekonomier/\&q; target\&q;_blank\&q; rel\&q;noreferrer noopener\&q;&g;https://www.newsoresund.se/svensk-och-dansk-life-science-industri-allt-viktigare-for-landernas-ekonomier/&l;/a&g;&l;br /&g;3: &l;a href\&q;https://www.vinnova.se/en/publikationer/statistics-on-swedish-life-science-companies/\&q;&g;https://www.vinnova.se/en/publikationer/statistics-on-swedish-life-science-companies/&l;/a&g;&l;/p&g;&q;,&q;companyAbout&q;:&q;&l;p&g;Branschorganisationen SwedenBIO arbetar f&a;ouml;r en konkurrenskraftig life science-sektor i Sverige. Vi g&a;ouml;r det genom att skapa effektiva kontaktytor mellan sektorns olika akt&a;ouml;rer, genom att bygga kunskap och genom att ge branschen en stark r&a;ouml;st i samh&a;auml;llsdebatten.&a;nbsp; &a;nbsp;V&a;aring;ra mer &a;auml;n 330 medlemsf&a;ouml;retag bedriver verksamhet inom l&a;auml;kemedelsutveckling, bioteknik, medicinteknik och diagnostik eller &a;auml;r experter inom bland annat aff&a;auml;rsutveckling, finansiering, immaterialr&a;auml;tt och juridik.&l;/p&g;&q;,&q;canonicalUrl&q;:null,&q;imageUrl&q;:&q;https://cdn.filestackcontent.com/auto_image/fojLeIS8T9i5hUoaL273&q;,&q;imageDescription&q;:&q;The Öresund bridge connecting Sweden and Denmark&q;,&q;imageAlt&q;:&q;The Öresund bridge connecting Sweden and Denmark&q;,&q;published&q;:&q;2024-08-20T09:44:04.276Z&q;,&q;created&q;:&q;2024-08-20T09:44:04.276&q;,&q;sluggedName&q;:&q;swedish-and-danish-life-science-experiencing&q;,&q;isFeatured&q;:false,&q;language&q;:&q;en&q;,&q;status&q;:&q;active&q;,&q;type&q;:&q;pressRelease&q;,&q;contacts&q;:,&q;topics&q;:{&q;id&q;:32837,&q;name&q;:&q;Nordic Life Science Days&q;,&q;count&q;:1,&q;sortOrder&q;:null},&q;relatedContent&q;:,&q;publishUrl&q;:&q;press.swedenbio.se/posts/pressreleases/swedish-and-danish-life-science-experiencing&q;},{&q;id&q;:302162,&q;title&q;:&q;Välkommet regeringsbesked om kliniska prövningar &q;,&q;summary&q;:&q;Regeringen gav igår ett viktigt besked kring hur Sverige ska nå målet om att öka antalet kliniska prövningar. SwedenBIO välkomnar beslutet som bygg...&q;,&q;description&q;:&q;&l;p&g;&l;strong&g;Regeringen gav ig&a;aring;r ett viktigt besked kring hur Sverige ska n&a;aring; m&a;aring;let om att &a;ouml;ka antalet kliniska pr&a;ouml;vningar. SwedenBIO v&a;auml;lkomnar beslutet som bygger p&a;aring; de f&a;ouml;rslag som utredaren Peter Asplund har lagt fram och som inneb&a;auml;r att ett nationellt partnerskap inr&a;auml;ttas.&a;nbsp;&l;/strong&g;&l;/p&g;\n&l;p&g;Regeringensbeskedet som annonserades den 27 juni inneb&a;auml;r att L&a;auml;kemedelsverket f&a;aring;r i uppdrag att f&a;ouml;resl&a;aring; &a;aring;tg&a;auml;rder f&a;ouml;r att f&a;ouml;rb&a;auml;ttra f&a;ouml;ruts&a;auml;ttningarna och st&a;auml;rka kapaciteten f&a;ouml;r kliniska pr&a;ouml;vningar i Sverige. Detta ska g&a;ouml;ras genom att ta avstamp i den tidigare publicerade utredningen &l;em&g;F&a;ouml;rslag p&a;aring; &a;aring;tg&a;auml;rder f&a;ouml;r att skapa b&a;auml;ttre f&a;ouml;ruts&a;auml;ttningar f&a;ouml;r kliniska pr&a;ouml;vningar (Ds 2023:8)&a;nbsp;&l;/em&g;d&a;auml;r f&a;ouml;rslaget att inr&a;auml;tta ett nationellt partnerskap, SweTrial presenterades.&a;nbsp;&l;/p&g;\n&l;p&g;SwedenBIO ser positivt p&a;aring; uppdraget som l&a;auml;mnats till L&a;auml;kemedelsverket och som g&a;aring;r helt i linje med det remissvar och p&a;aring;verkansarbete branschorganisationen har bedrivit sedan utredningen publicerats.&l;/p&g;\n&l;p&g;&a;ndash; Att vi har fyra ministrar som uttalar sig i samband med beslutet ser jag som en tydlig markering g&a;auml;llande vikten som regeringen l&a;auml;gger vid fr&a;aring;gan. Nu har vi goda f&a;ouml;ruts&a;auml;ttningar att kraftsamla f&a;ouml;r att v&a;auml;nda den negativa trenden med f&a;auml;rre kliniska pr&a;ouml;vningar, s&a;auml;ger Jessica Martinsson, vd f&a;ouml;r SwedenBIO.&a;nbsp;&l;/p&g;\n&l;p&g;Peter Asplund, regeringens utredare i fr&a;aring;gan, ser beskedet som ett viktigt och efterl&a;auml;ngtat regeringsbeslut f&a;ouml;r Sverige och svenska patienter.&a;nbsp;&l;/p&g;\n&l;p&g;&a;ndash; Att det h&a;auml;r f&a;ouml;rslaget tillsammans med tv&a;aring; av de andra f&a;ouml;rslagen i utredningen nu tas vidare st&a;auml;rker sannolikheten f&a;ouml;r att Sverige kan v&a;auml;nda utvecklingen, s&a;auml;rskilt d&a;aring; den l&a;aring;ngvarigt negativa trenden med allt f&a;auml;rre kliniska pr&a;ouml;vningar visat sig best&a;aring; ocks&a;aring; i statistiken f&a;ouml;r 2023.&a;nbsp;&l;/p&g;\n&l;p&g;Asplund betonar att ingen akt&a;ouml;r kan ensam v&a;auml;nda den negativa trenden och att det &a;auml;r v&a;auml;lkommet att regeringen sl&a;aring;r fast att kliniska pr&a;ouml;vningar &a;auml;r en v&a;auml;sentlig del av ett starkt life science Sverige och en v&a;auml;lf&a;auml;rdsfr&a;aring;ga.&a;nbsp;&l;/p&g;\n&l;p&g;&a;ndash; Akt&a;ouml;rerna i ekosystemet kan nu samlat sluta upp och uttala de &a;aring;taganden som kr&a;auml;vs. Och den &a;rsquo;F&a;auml;rdplan 2030 f&a;ouml;r kliniska pr&a;ouml;vningar&a;rsquo; som akt&a;ouml;rerna gemensamt arbetade fram inom ramen f&a;ouml;r utredningen &a;auml;r en solid grund f&a;ouml;r det.&a;nbsp;&l;/p&g;\n&l;p&g;Beslutet kommer under det p&a;aring;g&a;aring;ende arbetet med bland annat en uppdatering av life science strategin och beredningen av forskningspropositionen, d&a;auml;r regeringen ocks&a;aring; kan uttala en tydlig ambitionsniv&a;aring; mot vilken partnerskapet kan formulera m&a;aring;l och prioritera &a;aring;tg&a;auml;rder, menar Asplund.&a;nbsp;&l;/p&g;\n&l;p&g;&a;ndash; Det h&a;auml;r &a;auml;r en viktig signal till b&a;aring;de den forskande industrin, akademiska forskare och patienter att regeringen nu agerar f&a;ouml;r att ocks&a;aring; svensk h&a;auml;lso- och sjukv&a;aring;rd skall kunna s&a;auml;ga ja till flera kliniska pr&a;ouml;vningar och att vi &a;auml;r &a;auml;nnu b&a;auml;ttre rustade att ut&a;ouml;ka samarbetet med andra l&a;auml;nder, bland annat v&a;aring;ra nordiska grannl&a;auml;nder, s&a;auml;ger Peter Asplund.&a;nbsp;&l;/p&g;\n&l;p&g;Parallellt med L&a;auml;kemedelsverkets arbete kommer SwedenBIO att bidra till projektet &a;rdquo; St&a;auml;rkt konkurrenskraft f&a;ouml;r kliniska pr&a;ouml;vningar&a;rdquo; finansierat av Swelife. Projektet &a;auml;r en f&a;ouml;rstudie av delar av kliniska pr&a;ouml;vningar utredningen och syftar till att konkretisera hur det nationella partnerskapet ska utformas. SwedenBIO ansvarar f&a;ouml;r att ta fram kunskapsunderlag f&a;ouml;r internationella j&a;auml;mf&a;ouml;relser f&a;ouml;r att kunna locka r&a;auml;tt typ av pr&a;ouml;vningar till Sverige.&l;/p&g;&q;,&q;companyAbout&q;:&q;&l;p&g;Branschorganisationen SwedenBIO arbetar f&a;ouml;r en konkurrenskraftig life science-sektor i Sverige. Vi g&a;ouml;r det genom att skapa effektiva kontaktytor mellan sektorns olika akt&a;ouml;rer, genom att bygga kunskap och genom att ge branschen en stark r&a;ouml;st i samh&a;auml;llsdebatten.&a;nbsp; &a;nbsp;V&a;aring;ra mer &a;auml;n 330 medlemsf&a;ouml;retag bedriver verksamhet inom l&a;auml;kemedelsutveckling, bioteknik, medicinteknik och diagnostik eller &a;auml;r experter inom bland annat aff&a;auml;rsutveckling, finansiering, immaterialr&a;auml;tt och juridik.&l;/p&g;&q;,&q;canonicalUrl&q;:null,&q;imageUrl&q;:null,&q;imageDescription&q;:null,&q;imageAlt&q;:null,&q;published&q;:&q;2024-06-28T09:39:26.893Z&q;,&q;created&q;:&q;2024-06-28T09:39:26.893&q;,&q;sluggedName&q;:&q;valkommet-regeringsbesked-om-kliniska-provnin&q;,&q;isFeatured&q;:false,&q;language&q;:&q;sv&q;,&q;status&q;:&q;active&q;,&q;type&q;:&q;pressRelease&q;,&q;contacts&q;:,&q;topics&q;:,&q;relatedContent&q;:,&q;publishUrl&q;:&q;press.swedenbio.se/posts/pressreleases/valkommet-regeringsbesked-om-kliniska-provnin&q;}}}/script>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]